Attenuated familial adenomatous polyposis manifests as autosomal dominant late-onset colorectal cancer

Abdulla Ibrahim, Daniel R. Barnes, Jacqueline Dunlop, Daniel Barrowdale, Antonis C. Antoniou, Jonathan N. Berg (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    17 Citations (Scopus)

    Abstract

    Colorectal cancer (CRC) risk is well defined for families of patients with classical familial adenomatous polyposis (FAP). However, the risk for those with an attenuated form of FAP is less well characterised. In this study, we estimated CRC risks for carriers of a novel germline mutation in the APC gene that causes attenuated FAP (AFAP). We performed genetic testing on 53 individuals from seven AFAP families harbouring an identical APC:c.288T>A mutation. Using a modified segregation analysis, we estimated relative and absolute CRC risks for mutation carriers. Twenty-three individuals harboured the disease causing mutation. CRC occurred in 28 individuals (mean 61.7 years, range 32-80 years). The estimated CRC relative risks for mutation carriers aged 60-69 and ≥70 years were 19 (95% CI: 1.77-204.08) and 45 (95% CI: 11.32-180.10), respectively, while the absolute CRC lifetime risk for men was 94% (95% CI: 67.5-99.9%), and for women, 84% (95% CI: 50.9-99.0%). This study shows that AFAP can manifest as autosomal dominant late-onset CRC. These findings highlight a subgroup of inherited CRCs that require new criteria for identification and surveillance.

    Original languageEnglish
    Pages (from-to)1330-1333
    Number of pages4
    JournalEuropean Journal of Human Genetics
    Volume22
    Issue number11
    DOIs
    Publication statusPublished - Nov 2014

    Keywords

    • APC
    • attenuated FAP
    • colorectal cancer risk
    • FAP
    • segregation analysis

    ASJC Scopus subject areas

    • Genetics(clinical)
    • Genetics

    Fingerprint

    Dive into the research topics of 'Attenuated familial adenomatous polyposis manifests as autosomal dominant late-onset colorectal cancer'. Together they form a unique fingerprint.

    Cite this